Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wellgistics Health (WGRX) Liabilities and Shareholders Equity (2024 - 2025)

Wellgistics Health's Liabilities and Shareholders Equity history spans 2 years, with the latest figure at $30.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 46.87% year-over-year to $30.5 million, compared with a TTM value of $195.5 million through Dec 2025, up 241.04%, and an annual FY2025 reading of $30.5 million, down 46.87% over the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $30.5 million at Wellgistics Health, down from $52.8 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $58.1 million in Q1 2025, with the low at $30.5 million in Q4 2025.